| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/07/2011 | CN101693740B Homerl protein and application thereof in treating or preventing cerebral injury disease |
| 09/07/2011 | CN101607992B Antibacterial peptide separated from cow blood and code sequence and application thereof |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101559215B Skin physiology repair liquid and preparation method thereof |
| 09/07/2011 | CN101543626B Medicament for preventing and curing thrombus and preparation method thereof |
| 09/07/2011 | CN101543625B Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/07/2011 | CN101525386B Fusion protein of Exendin-4 tandem polypeptide and human serum albumin, preparation and application thereof |
| 09/07/2011 | CN101503461B Polypeptide with liver cancer apoptosis reducing function |
| 09/07/2011 | CN101486758B Mda-7/IL-24 mutant polypeptide, and preparation and use thereof |
| 09/07/2011 | CN101469016B Trichosanthin protein derived peptide and use thereof |
| 09/07/2011 | CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 09/07/2011 | CN101429525B Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 09/07/2011 | CN101380461B Efficient thymosin enteric-coated tablets and thymosin for injection |
| 09/07/2011 | CN101163716B Interleukin-6 polyethylene glycol conjugate and its preparing method and use |
| 09/07/2011 | CN101037691B CENP-E combined protein and encoding gene and application |
| 09/06/2011 | US8013208 Methods for producing antibodies |
| 09/06/2011 | US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
| 09/06/2011 | US8013133 Genetic modification of targeted regions of the cardiac conduction system |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8013124 for stimulating the immune system, and proliferation and/or development of hematopoietic cells; production of proinflammatory cytokines |
| 09/06/2011 | US8013118 Lynx polypeptides |
| 09/06/2011 | US8013116 Therapeutic peptides and method |
| 09/06/2011 | US8013113 FRET protease assays for clostridial toxins |
| 09/06/2011 | US8013112 Compositions comprising human brain natriuretic peptide (BNP) fragments |
| 09/06/2011 | US8013022 Stabilized products, process and devices for preparing same |
| 09/06/2011 | US8013014 Aza-peptide epoxides |
| 09/06/2011 | US8012996 Methods and composition for inhibition of angiogenesis |
| 09/06/2011 | US8012946 Anti-angiogenic methods and compositions |
| 09/06/2011 | US8012939 Macrocyclic inhibitors of hepatitis C virus |
| 09/06/2011 | US8012938 Proteins of the "uncoupling proteins" family, with another active agent; obesity, diabetes, hyperlipidemia |
| 09/06/2011 | US8012936 Tau fragments for immunotherapy |
| 09/06/2011 | US8012935 Oligopeptide for blocking cancer |
| 09/06/2011 | US8012934 Small peptides and methods for treatment of inflammation |
| 09/06/2011 | US8012933 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 09/06/2011 | US8012932 Contraceptives based on SP22 and SP22 antibodies |
| 09/06/2011 | US8012931 Modified FGF-21 polypeptides and their uses |
| 09/06/2011 | US8012930 Methods of treating pervasive development disorders |
| 09/06/2011 | US8012929 Peptides directed for diagnosis and treatment of amyloid-associated diseases |
| 09/06/2011 | US8012928 Truncated PAP2 and methods of making and using same |
| 09/06/2011 | US8012927 Platelet promoting protein and the usage thereof |
| 09/06/2011 | US8012926 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012924 Amino acid composition and supplementary liquid containing the same |
| 09/06/2011 | US8012754 Antibody compositions |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012739 Methods and compositions for the production of orthogonal tRNA-aminoacyl-tRNA synthetase pairs |
| 09/06/2011 | US8012728 Thrombin preparations and process for their production |
| 09/06/2011 | US8012707 MN gene and protein |
| 09/06/2011 | US8012704 Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their use |
| 09/06/2011 | US8012694 Assay for the detection of phosphorylated PTH |
| 09/06/2011 | US8012693 Analysis of chemically crosslinked cellular samples |
| 09/06/2011 | US8012692 Elastin peptide fingerprints and analysis methods for MMP12 related to COPD |
| 09/06/2011 | US8012509 Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases |
| 09/06/2011 | US8012491 Recombinant toxin fragments |
| 09/06/2011 | US8012487 Amino acid sequence comprising immunogenic epitope cluster for use as tool in diagnosis and treatment of autoimmune disorders |
| 09/06/2011 | US8012481 More than one dopamine receptor agonist such as apomorphine, ropinirole, pramipexole, pergoline, cabergoline, SKF-81297; and/or more than one noradrenaline/dopamine precursor and/or more than one serotonin receptor agonist; spinal cord injuries; nervous system disorders; paraplegics or tetraplegics |
| 09/06/2011 | US8012480 Detection of proteins from circulating neoplastic cells |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012475 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 09/06/2011 | US8012471 Use of polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides in therapy of various dysfunctions, disorders or diseases, particularly cardiovascular, metabolic, and neurodegenerative disorders |
| 09/06/2011 | US8012465 Methods for treating renal cell carcinoma |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2452260C Novel variants and exons of the glyt1 transporter |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2335230C Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 09/04/2011 | CA2695337A1 Compositions and methods for inhibition of hiv |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/01/2011 | WO2011106788A2 Car peptide for homing, diagnosis, & targeted therapy for pulmonary and fibrotic disorders |
| 09/01/2011 | WO2011106717A1 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| 09/01/2011 | WO2011106703A2 Cxcr4 receptor compounds |
| 09/01/2011 | WO2011106697A1 Therapeutic compositions for the treatment of dry eye disease |
| 09/01/2011 | WO2011106684A2 Compositions and methods for modulating autophagy |
| 09/01/2011 | WO2011106635A1 Treatment of sepsis using complement inhibitors |
| 09/01/2011 | WO2011106396A1 Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios |
| 09/01/2011 | WO2011106376A2 Use of microvesicles in the treatment of medical conditions |
| 09/01/2011 | WO2011106234A1 Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 09/01/2011 | WO2011106086A1 Pegylated albumin polymers and uses thereof |
| 09/01/2011 | WO2011105658A1 Cell protectants comprising placenta extracts |
| 09/01/2011 | WO2011105527A1 Nerve growth promoter |
| 09/01/2011 | WO2011105435A1 Therapeutic agent for eating disorders |
| 09/01/2011 | WO2011105431A1 Antibacterial auxiliary agent comprising kombu extract as active ingredient, antibacterial composition, and food or beverage |
| 09/01/2011 | WO2011104971A1 Composition for controlling weight gain and food product containing the same |
| 09/01/2011 | WO2011104708A2 Methods for inhibiting necrosis |
| 09/01/2011 | WO2011104621A1 Surfactant composition |
| 09/01/2011 | WO2011104552A1 Stable compositions of factor ix |
| 09/01/2011 | WO2011104379A1 Peptides for treatment of obesity |
| 09/01/2011 | WO2011104378A1 Peptides for treatment of obesity |
| 09/01/2011 | WO2011104352A1 Oral lactoferrin in the treatment of severe sepsis |
| 09/01/2011 | WO2011104309A1 Compounds for the treatment of inflammation and neutropenia |
| 09/01/2011 | WO2011103920A2 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | WO2011103877A1 Process for production and purification of recombinant lysosomal alpha-mannosidase |
| 09/01/2011 | WO2011103666A1 Modulation of cytokine-induced chronic inflammatory responses |
| 09/01/2011 | WO2011103624A1 Method of treatment or prevention of hair loss or for the enhancement of hair growth |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | WO2011056713A3 Glp-1 receptor agonist compounds for obstructive sleep apnea |
| 09/01/2011 | WO2011041325A3 Methods and compositions for the treatment of viral disorders |
| 09/01/2011 | WO2011036445A3 Polypeptides and uses thereof |
| 09/01/2011 | WO2011020114A3 Methods of treating cancer using tachykinin retargeted endopeptidases |
| 09/01/2011 | WO2011017554A4 Val (8) glp-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |